These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25511507)

  • 1. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
    Campion P
    Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speed of response to electroconvulsive therapy compared with ketamine.
    Kellner CH; ; Lisanby SH; Weiner R; Prudic J; Rudorfer MV; Young RC; Petrides G; McCall WV; Husain M; Greenberg RM; Knapp RG
    Psychiatry Res; 2015 Jan; 225(1-2):215. PubMed ID: 25511506
    [No Abstract]   [Full Text] [Related]  

  • 4. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
    Kellner CH; Greenberg RM; Ahle GM; Liebman LS
    Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.
    Goforth HW; Holsinger T
    J ECT; 2007 Mar; 23(1):23-5. PubMed ID: 17435569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving Issues in the Treatment of Depression.
    Köhler-Forsberg O; Cusin C; Nierenberg AA
    JAMA; 2019 Jun; 321(24):2401-2402. PubMed ID: 31125042
    [No Abstract]   [Full Text] [Related]  

  • 7. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 8. A word to the wise about ketamine.
    Schatzberg AF
    Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression.
    Zhang M; Rosenheck R; Lin X; Li Q; Zhou Y; Xiao Y; Huang X; Fan N; He H
    J Affect Disord; 2018 Feb; 227():372-378. PubMed ID: 29149755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression.
    Kallmünzer B; Volbers B; Karthaus A; Tektas OY; Kornhuber J; Müller HH
    J Neural Transm (Vienna); 2016 May; 123(5):549-52. PubMed ID: 26721476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: A meta-analysis.
    Li DJ; Wang FC; Chu CS; Chen TY; Tang CH; Yang WC; Chow PC; Wu CK; Tseng PT; Lin PY
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):29-41. PubMed ID: 27908572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report.
    Gálvez V; O'Keefe E; Cotiga L; Leyden J; Harper S; Glue P; Mitchell PB; Somogyi AA; DeLory A; Loo CK
    Biol Psychiatry; 2014 Aug; 76(3):e1-2. PubMed ID: 24507509
    [No Abstract]   [Full Text] [Related]  

  • 14. Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
    Zhang MW; Ho R
    Am J Psychiatry; 2016 Apr; 173(4):431. PubMed ID: 27035535
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
    Ibrahim L; Diazgranados N; Luckenbaugh DA; Machado-Vieira R; Baumann J; Mallinger AG; Zarate CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1155-9. PubMed ID: 21466832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Zhang and Ho: Addressing Ketamine's Use in Depression.
    Newport DJ; Nemeroff CB
    Am J Psychiatry; 2016 Apr; 173(4):431-2. PubMed ID: 27035536
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.
    Blier P
    Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.
    Fernie G; Currie J; Perrin JS; Stewart CA; Anderson V; Bennett DM; Hay S; Reid IC
    Br J Psychiatry; 2017 Jun; 210(6):422-428. PubMed ID: 28254962
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketamine and Electroconvulsive Therapy for Depression.
    Andrade C
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):288-289. PubMed ID: 30001277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.